Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001121404-23-000002
Filing Date
2023-02-03
Accepted
2023-02-03 11:40:39
Documents
6
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 6-K a6kcoverpagepressreleaseq4.htm 6-K 14837
2 EX-99.1 pressreleaseq42022english.htm EX-99.1 1162874
3 GRAPHIC chart-77caa408d3724fb9a48.jpg GRAPHIC 60216
4 GRAPHIC chart-8f98b6910d09426f888.jpg GRAPHIC 75635
5 GRAPHIC esgratingsq4v2.jpg GRAPHIC 47544
6 GRAPHIC image.jpg GRAPHIC 4047
  Complete submission text file 0001121404-23-000002.txt   1437579
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 23584471
SIC: 2834 Pharmaceutical Preparations